# Single-Cell Sequence Technology Used to Reveal Heterogeneity of Secondary Hyperparathyroidism

> **NCT06130683** · — · ACTIVE_NOT_RECRUITING · sponsor: **China-Japan Friendship Hospital** · enrollment: 12 (estimated)

## Conditions studied

- Secondary Hyperparathyroidism

## Interventions

- **OTHER:** Single-cell sequencing

## Key facts

- **NCT ID:** NCT06130683
- **Lead sponsor:** China-Japan Friendship Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-11-10
- **Primary completion:** 2024-12-08
- **Final completion:** 2025-07-31
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2024-12-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06130683

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06130683, "Single-Cell Sequence Technology Used to Reveal Heterogeneity of Secondary Hyperparathyroidism". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT06130683. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*